Projects per year
Projects 2000 3013
- 1 - 50 out of 9,000 results
- Status, start date (descending)
Active
A Comprehensive Framework for Modelling the Human Connectome
Fornito, A., Deco, G. & Aquino, K. M.
19/02/20 → 18/02/23
Project: Research
Targeting site specific improvements of clinical trial operational processes
Mazzitelli, B. & Law, R.
17/02/20 → 17/07/20
Project: Research
Gene-transfer, open-label, dose escalation study of SPK-8011 [adeno-associated viral vector with B-domain-deleted human factor VIII gene] in individuals with haemophilia A
Tran, H. & Kennedy, N.
14/02/20 → 31/12/25
Project: Research
A Phase 1b/III study of Ipatasertib plus Palbociclib and Fulvestrant versus placebo plus Palbociclib and Fulvestrant in hormone receptor positive and Her2 negative locally advanced unresectable or metastatic breast cancer [Ipatunity150] [CO41012]
Antill, Y., Baker, E. & Thompson, K.
13/02/20 → 31/12/25
Project: Research
An open-label, multi-center, long-term extension study of Zanubrutinib (BGB-3111) in patients with B-cell malignancies
Kenealy, M. & Baker, E.
13/02/20 → 31/12/25
Project: Research
Fins to Limbs: Investigating the Evolution of complex Limb Musculature
Currie, P., Trinajstic, K. M. & Tulenko, F.
12/02/20 → 31/12/22
Project: Research
A Phase 3, Randomized, Double-Blind Study of Adjuvant Immunotherapy with Nivolumab versus Placebo after Complete Resection of Stage IIB/C Melanoma.
Haydon, A. & Hawkins, C.
12/02/20 → 31/12/25
Project: Research
A Phase 1b, Multi-center, Randomized, Double blind, Placebo-controlled Study to Investigate the Efficacy, Safety and Pharmacokinetics of CSL312 in the Prevention of Peripherally Inserted Central Catheter (PICC)-associated Thrombosis in Subjects with Cancer
Tran, H., Chunilal, S., Casey, J. & Kennedy, N.
10/02/20 → 31/12/25
Project: Research
Open Label Extension Study for Patients with Early Alzheimer's Disease (AD) Enrolled in Study ANAVEX2-73-AD-004.
O'Brien, T. & Burn, K.
7/02/20 → 31/12/22
Project: Research
A Phase III, Randomized, Double-blind Trial Comparing Trastuzumab Plus Chemotherapy and Pembrolizumab With Trastuzumab Plus Chemotherapy and Placebo as Firstline Treatment in Participants With HER2 Positive Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (KEYNOTE 811)
6/02/20 → 5/02/25
Project: Research
Reproducibility and transparency in the synthesis of research findings
Australian Research Council (ARC)
3/02/20 → 2/02/23
Project: Research
Developing a suite of short, low-cost, online micro-credentialed courses to support healthcare improvement innovation and impact
Skouteris, H., Currie, G., Teede, H. & Crump, B.
Monash University – Internal University Contribution, University of Warwick
3/02/20 → 30/07/21
Project: Research
Utilising digital training technology to support cognitive skill development and enhance learning in primary school children
Kirk, H., Cornish, K., Bellgrove, M., Spencer-Smith, M., Jobson, L. & Adams, K.
Monash University – Internal Faculty Contribution, Monash University – Internal Department Contribution
3/02/20 → 29/04/22
Project: Research
How exercise modulates neural plasticity and memory consolidation
Coxon, J., Byblow, W. D. & Hawi, Z.
3/02/20 → 31/12/22
Project: Research
Churchill Fellowship: Environmental sustainability of hospital foodservice
1/02/20 → 31/01/21
Project: Research
Sphingosine Kinase-1 Inhibitors for the Treatment of Pulmonary Hypertension
1/02/20 → 1/02/21
Project: Research
Program Development and Evaluation of Relationship Australia Victoria’s (RAV) service delivery to support people affected by the Royal Commission into Violence, Abuse, Neglect and Exploitation of People with Disability
Skouteris, H. & O'Connor, M.
Relationships Australia Victoria
1/02/20 → 31/01/21
Project: Research
Checkpoint receptors expressed by dendritic cells- do they play a role in immunotherapies?
1/02/20 → 31/01/23
Project: Research
Airway clearance techniques for Indigenous adults with Bronchiectasis
Lee, A. & Nicolson, C.
Australian Physiotherapy Association
1/02/20 → 31/01/22
Project: Research
Heart Matters: a Heart Safe Communities partnership to improve cardiovascular awareness and response to symptoms in regions at highest risk of heart attacks.
Bray, J., Finn, J., Clark, R. A., Nehme, Z., Stub, D., Smith, K. L., Chow, C., Cadilhac, D., Kasza, J. & Cameron, P.
National Health & Medical Research Council (NHMRC), Heart Foundation, Victorian Department of Health and Human Services
1/02/20 → 31/01/23
Project: Research
A Phase 3 Multicenter, Randomized, Double-blinded, Active-controlled, Clinical Study to Evaluate the Safety and Efficacy of Lenvatinib (E7080/MK-7902) in Combination with Pembrolizumab (MK-3475) Versus Lenvatinib in First-line Therapy of Participants with Advanced Hepatocellular Carcinoma
24/01/20 → 23/01/25
Project: Research
A pilot randomised controlled trial (RCT) of personalised approach bias modification for methamphetamine use disorder
Manning, V., Garfield, J., Arunogiri, S., Lubman, D., Gavin, J., Kotler, E., George, S., Okedara, G. & Hopwood, M.
National Centre for Clinical Research on Emerging Drugs
24/01/20 → 2/10/20
Project: Research
Long-term safety and effectiveness evaluation of participants treated with NovoSorb Biodegradable Temporising Matrix (BTM) for dermal repair: An observational cohort study
Salerno, S. & Thompson, K.
21/01/20 → 31/12/20
Project: Research
Data-driven diagnoses and treatments for neurodevelopmental disorders.
Bellgrove, M., Johnson, B., Cornish, K., Kirk, H., Williams, K. & Hawi, Z.
Australian Government Department of Health
20/01/20 → 30/06/24
Project: Research
A Two-Part, Randomized, Open-label, Multicenter, Phase 2a/2b Study of the Efficacy, Safety, and Pharmacokinetics of KRT-232 Compared to Ruxolitinib in Patients with Phlebotomy-Dependent Polycythemia Vera (KRT-232-102)
Perkins, A., Burbury, K. L. & Kennedy, N.
20/01/20 → 31/12/25
Project: Research
Effective Patient Modelling to Support Decision Making in Discharge Planning
Wu, M., Buntine, W., Wang, T., Bingham, G., Skouteris, H. & Bain, C.
20/01/20 → 19/01/23
Project: Research
An Open-Label, Phase 2a/2b Study of KRT-232 in Subjects With Primary Myelofibrosis (PMF), Post–Polycythemia Vera MF (Post-PV-MF), Or Post–Essential Thrombocythemia MF(Post–ET-MF) Who Have Failed Prior Treatment with a JAK Inhibitor (KRT-232-101)
Perkins, A. & Kennedy, N.
20/01/20 → 31/12/25
Project: Research
Efficacy and Safety of Concizumab prophylaxis in patients with haemophilia A or B without inhibitors (Explorer8)
Tran, H. & Kennedy, N.
20/01/20 → 31/12/25
Project: Research
A Phase 1, Open-label, Multiple-Ascending Dose Study of the Safety and Tolerability of T3011 in Advanced Cutaneous or Subcutaneous Malignancies
Haydon, A. & Hawkins, C.
20/01/20 → 31/12/25
Project: Research
Efficacy and Safety of Concizumab prophylaxis in patients with haemophilia A or B with inhibitors (Explorer7).
Tran, H. & Kennedy, N.
20/01/20 → 31/12/25
Project: Research
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Clinical Outcomes, Antiviral Activity, Safety, Tolerability, Pharmacokinetics, and Pharmacokinetics/Pharmacodynamics of JNJ-53718678 in Adult and Adolescent Hematopoietic Stem Cell Transplant Recipients with Respiratory Syncytial Virus Infection of the Upper Respiratory Tract (FREESIA)
Kliman, D., Kennedy, N. & Thompson, K.
15/01/20 → 31/12/25
Project: Research
Defining the basis of unconventional immune cell development
Australian Research Council (ARC)
13/01/20 → 12/01/23
Project: Research
An international program of research to improve outcomes for patients with acute heart failure
10/01/20 → 21/07/20
Project: Research
SRMRSTDC: Selective regulation of mineralocorticoid receptor (MR) signalling for the treatment of diabetic cardiac myopathies
1/01/20 → 31/12/20
Project: Research
Defining the role of niche-derived Neuregulin-1 in intestinal regeneration
1/01/20 → 31/12/23
Project: Research